Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/27474| Title: | Justification for valsartan and telmisartan prescribing to patients with coronary artery disease and diabetes melitus type 2 |
| Authors: | Koshkina, Marharyta Кошкіна, Маргарита Володимирівна |
| Keywords: | coronary artery disease type 2 diabetes mellitus |
| Issue Date: | Oct-2020 |
| Citation: | Koshkina M. Justification for valsartan and telmisartan prescribing to patients with coronary artery disease and diabetes melitus type 2 / M. Koshkina // ISIC-2020 : [International Scientific Interdisciplinary Conference for medical students and young scientists, Kharkiv, 8–9 October, 2018]: abstract book / KNMU. – Kharkiv, 2020. – P. 70. |
| Abstract: | Introduction: It is known that there is a need to prescribe blood pressure control drugs to patients with coronary artery disease (CAD). Among them there is the reninangiotensin-aldosterone system blockers group (ARBs). There is evidence that the designation of ARBs improves predictions of the progress of CAD. |
| URI: | https://repo.knmu.edu.ua/handle/123456789/27474 |
| Appears in Collections: | Наукові роботи молодих вчених. Кафедра внутрішньої медицини № 2 і клінічної імунології та алергології ім. ак. Л.Т. Малої |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.